News
Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center have extended and expanded a collaboration exploring medicines targeting lung cancer with KRAS mutations. The ...
All the patients in the phase 2 study received cyclophosphamide, tacrolimus and mycophenolate mofetil for graft-vs-host ...
3d
Zacks Investment Research on MSNDGX Stock Up on New Blood Test Development Deal With MD AndersonQuest Diagnostics Inc. DGX recently announced a collaboration with The University of Texas MD Anderson Cancer Center (MD Anderson). The partnership will focus on improving the assessment of elevated ...
Our nurse anesthetist program prepares students for the challenges they'll face as Certified Registered Nurse Anesthetists (CRNA). Our nurse anesthetist students receive an education that equips them ...
Certified anesthesiologist assistants are highly skilled healthcare professionals who work under the direction of licensed anesthesiologists to implement anesthesia care plans. CAAs work exclusively ...
In the classroom, activity-based costing looks like a great way to manage a company’s limited resources. But many managers who have tried to implement ABC in their organizations on any ...
In Bethel’s Department of Nursing, you’ll be prepared to provide a Christ-like presence in healthcare settings locally and around the world. You’ll develop strong leadership skills in nursing practice ...
See expanded profiles of nearly 1,800 schools. Unlock entering class stats including MCAT, GMAT and GRE scores.
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
CHICAGO — In this video, Susana M. Campos, MD, MPH, discusses results from a phase 2 trial of pembrolizumab and lenvatinib for patients with recurrent or persistent clear-cell ovarian cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results